ArticleFuture oncology (London, England)2025

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE).

Anwaar Saeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.